Shanghai Kehua Biological Engineering Overview

  • Year Founded
  • 1981

Year Founded

  • Status
  • Public

  • Employees
  • 1,870

Employees

  • Stock Symbol
  • 002022

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $0.69
  • (As of Friday Closing)

Shanghai Kehua Biological Engineering General Information

Description

Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.

Contact Information

Website
www.skhb.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No. 1189 Qinzhou North Road
  • Caohejing Emerging Technology Development Zone, Xuhui District
  • Shanghai, 200233
  • China
+86 021
Primary Industry
Diagnostic Equipment
Stock Exchange
SHE
Corporate Office
  • No. 1189 Qinzhou North Road
  • Caohejing Emerging Technology Development Zone, Xuhui District
  • Shanghai, 200233
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanghai Kehua Biological Engineering Stock Performance

As of 20-Nov-2026, Shanghai Kehua Biological Engineering’s stock price is $0.69. Its current market cap is $364M with 531M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.69 $0.72 $0.66 - $1.08 $364M 531M 9.6M -$0.19

Shanghai Kehua Biological Engineering Financials Summary

As of 30-Sep-2026, Shanghai Kehua Biological Engineering has a trailing 12-month revenue of $249M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 538,383 495,508 476,193 781,100
Revenue 249,094 228,398 245,169 343,197
EBITDA (97,232) (77,374) (65,168) 6,097
Net Income (95,522) (101,809) (89,277) (33,077)
Total Assets 633,655 663,375 717,268 960,379
Total Debt 64,621 99,862 64,349 128,017
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shanghai Kehua Biological Engineering Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shanghai Kehua Biological Engineering‘s full profile, request access.

Request a free trial

Shanghai Kehua Biological Engineering Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in Chi
Diagnostic Equipment
Shanghai, China
1,870 As of 2025

Villepinte, France
 

Crumlin, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Shanghai Kehua Biological Engineering Competitors (28)

One of Shanghai Kehua Biological Engineering’s 28 competitors is Guerbet Group, a Corporation company based in Villepinte, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Guerbet Group Corporation Villepinte, France
Randox Laboratories Corporation Crumlin, United Kingdom
Agappe Diagnostics Formerly PE-Backed Ernakulam, India
Biocartis Venture Capital-Backed Mechelen, Belgium
Abbott Corporation Abbot Park, IL
You’re viewing 5 of 28 competitors. Get the full list »

Shanghai Kehua Biological Engineering Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shanghai Kehua Biological Engineering Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Shanghai Kehua Biological Engineering‘s full profile, request access.

Request a free trial

Shanghai Kehua Biological Engineering Investments & Acquisitions (7)

Shanghai Kehua Biological Engineering’s most recent deal was a Early Stage VC with ArrayHope. The deal was made on 05-Sep-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ArrayHope 05-Sep-2024 Early Stage VC Diagnostic Equipment
Xi'an TianLong Science and Technology 28-Sep-2022 Merger/Acquisition Discovery Tools (Healthcare)
Suzhou Tianlong Biotechnology 29-Jun-2018 Merger/Acquisition Diagnostic Equipment
Xi'an TianLong Science and Technology 11-Jun-2018 Secondary Transaction - Private Discovery Tools (Healthcare)
Igenesisbio 21-Dec-2017 Corporate Diagnostic Equipment
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Shanghai Kehua Biological Engineering ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Shanghai Kehua Biological Engineering’s complete esg history, request access »

Shanghai Kehua Biological Engineering Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Xi'an TianLong Science and Technology Xi'an, China 1997
Suzhou Tianlong Biotechnology Suzhou, China 1997

Shanghai Kehua Biological Engineering FAQs

  • When was Shanghai Kehua Biological Engineering founded?

    Shanghai Kehua Biological Engineering was founded in 1981.

  • Where is Shanghai Kehua Biological Engineering headquartered?

    Shanghai Kehua Biological Engineering is headquartered in Shanghai, China.

  • What is the size of Shanghai Kehua Biological Engineering?

    Shanghai Kehua Biological Engineering has 1,870 total employees.

  • What industry is Shanghai Kehua Biological Engineering in?

    Shanghai Kehua Biological Engineering’s primary industry is Diagnostic Equipment.

  • Is Shanghai Kehua Biological Engineering a private or public company?

    Shanghai Kehua Biological Engineering is a Public company.

  • What is Shanghai Kehua Biological Engineering’s stock symbol?

    The ticker symbol for Shanghai Kehua Biological Engineering is 002022.

  • What is the current stock price of Shanghai Kehua Biological Engineering?

    As of 20-Nov-2026 the stock price of Shanghai Kehua Biological Engineering is $0.69.

  • What is the current market cap of Shanghai Kehua Biological Engineering?

    The current market capitalization of Shanghai Kehua Biological Engineering is $364M.

  • What is Shanghai Kehua Biological Engineering’s current revenue?

    The trailing twelve month revenue for Shanghai Kehua Biological Engineering is $249M.

  • Who are Shanghai Kehua Biological Engineering’s competitors?

    Guerbet Group, Randox Laboratories, Agappe Diagnostics, Biocartis, and Abbott are some of the 28 competitors of Shanghai Kehua Biological Engineering.

  • What is Shanghai Kehua Biological Engineering’s annual earnings per share (EPS)?

    Shanghai Kehua Biological Engineering’s EPS for 12 months was -$0.19.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process